← Leaderboards
Keith Anderson
Synthomics, Inc.
$1,133,000
Attributed
$1,133,000
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $649K · FY2013–15$1M$750K$500K$250K$0
'13
'14
'15
Funding mix
By agency
NIH$1,133,000 · 2
By mechanism
R44$997,900 · 1
R43$135,100 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Anticancer Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$343,753,842
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$238,320,768
- Leonard Freedman · Leidos Biomedical Research, Inc.$161,112,755
- Richard L Schilsky · University Of Chicago$115,110,806
- Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
- Peter J O'Dwyer · University Of Pennsylvania$84,906,759
Research focus
Anticancer ResearchAreaBaseBiological ResearchBiologyCancer CellCommercializationCommunitiesComputer SoftwareCostDesignDetectionDiagnosticDiagnostics ResearchDna Microarray ChipDna ResequencingDna SequenceEngineeringEnvironmentExomeGenesGene TherapyGeometryAlgorithms
Grant awards (3)
Instrumentation enabling a 16-fold decrease in oligonucleotide cost$348,950
R44 · FY2015 · HG · contact PI
Instrumentation enabling a 16-fold decrease in oligonucleotide cost$648,950
R44 · FY2014 · HG · contact PI
Instrumentation enabling a 16-fold decrease in oligonucleotide cost$135,100
R43 · FY2013 · HG · contact PI